Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine

Size	Price	Stock	Quantity
5 g	$1573	In stock

Size

Price

Stock

Quantity

5 g

$1573

In stock

Purity

>98.0%

Solubility

10 mm in DMSO

Appearance

Colourless oil

ShelfLife

-20°C 3 years powder; -80°C 2 years in solvent

Storage

Store at -20 °C, keep in dry and avoid sunlight.

Shipping

Room temperature, or blue ice upon request.

IUPACName

tert-butyl 3-[2-amino-3-[3-[(2-methylpropan-2-yl)oxy]-3-oxopropoxy]-2-[[3-[(2-methylpropan-2-yl)oxy]-3-oxopropoxy]methyl]propoxy]propanoate

Synonyms

Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane; tert-butyl 3,3'-(2-amino-2-((3-tert-butoxy-3-oxopropoxy)methyl)propane-1,3-diyl)bis(oxy)dipropanoate

InChI Key

KPXODPHVWBQJEG-UHFFFAOYSA-N

InChI

InChI=1S/C25H47NO9/c1-22(2,3)33-19(27)10-13-30-16-25(26,17-31-14-11-20(28)34-23(4,5)6)18-32-15-12-21(29)35-24(7,8)9/h10-18,26H2,1-9H3

Canonical SMILES

CC(C)(C)OC(=O)CCOCC(COCCC(=O)OC(C)(C)C)(COCCC(=O)OC(C)(C)C)N

HNMR

How does Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine selectively degrade target proteins?

Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

21/12/2019

synthesize antibody-drug conjugates (ADCs)

Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is used in the synthesis of antibody-drug conjugates (ADCs) in my experiment. The quality is very good.

14/4/2018

synthesize PROTACs

We used Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine to synthesize PROTACs. The purity is very high.

22/7/2019

Stock concentration: *

Desired final volume: *

Desired concentration: *

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C₁V₁ = C₂V₂